# US 2021/0172964 A1 · Reference standard for bnp measurement

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0172964 A1
- Document ID: US20210172964A1
- Status: Published application
- Kind: A1
- Application number: 16/772,036
- Filed: 2018-12-28
- Published: 2021-06-10
- Earliest claimed: 2017-12-28
- Assignees: Shionogi & Co., Ltd.
- Applicants: Shionogi & Co., Ltd.
- Inventors: Norio OTA; Keiichi MASUTA
- Web page: https://patentgrep.com/patent/US20210172964A1

## CPC

- G01N 33/74: involving hormones {or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors}
- C07K 14/575: Hormones (derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin C07K14/665, e.g. corticotropin C07K14/695)
- G01N 2333/58: Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A reference standard set for BNP measurement, including a plurality of reference standards including BNP-32 and proBNP, wherein the ratio BNP-32/proBNP (mole ratio) differs between the reference standards, and when a reference standard having a high mole ratio and a reference standard having a low mole ratio are compared, the BNP concentration, which is the sum total of the BNP-32 concentration and the proBNP concentration, is lower in the reference standard having a high mole ratio than in the reference standard having a low mole ratio. The present invention makes it possible to provide: a reference standard set for BNP measurement, whereby, when the BNP concentration value of a specimen measured by a certain BNP measurement method and the BNP concentration value of the specimen measured by another BNP measurement method are corrected using the reference standard set for BNP measurement, the corrected measurement values can be made to more closely coincide in comparison with a case in which the measurement values are corrected using a conventional reference standard; and a method for correcting, using the reference standard set for BNP measurement, the measured BNP concentration value of a specimen.

## Claims

### Claim 1

A BNP assay standard set comprising a plurality of standards, each containing BNP-32 and proBNP, wherein BNP-32/proBNP (a mole ratio) differs among the standards; and when the standard at a high mole ratio and the standard at a low mole ratio are compared with each other, the standard at a high mole ratio has a lower BNP concentration that is the sum value of BNP-32 and proBNP concentrations than the standard at a low mole ratio.

### Claim 2 (depends on 1)

The BNP assay standard set according to claim 1, wherein the set comprises at least two standards, wherein the mole ratio (BNP-32/proBNP) of a first standard is from 40/60 to 60/40, and the mole ratio (BNP-32/proBNP) of a second standard is from 15/85 to 35/65.

### Claim 3 (depends on 2)

The BNP assay standard set according to claim 2, wherein the first standard has a BNP concentration of from 20 to 75 pg/mL and the second standard has a BNP concentration of from 150 to 300 pg/mL.

### Claim 4 (depends on 1)

A BNP assay kit comprising the BNP assay standard set according to claim 1.

### Claim 5 (depends on 1)

A BNP assay kit comprising information about a correction factor determined using the BNP assay standard set according to claim 1.

### Claim 6 (depends on 1)

A method for measuring a BNP concentration in a sample, comprising using the BNP assay standard set according to claim 1.

### Claim 7 (depends on 1)

A method for correcting a BNP concentration value measured in a sample, comprising using the BNP assay standard set according to claim 1.

### Claim 8 (depends on 7)

The method according to claim 7, further comprising the following steps (A) and (B):
(A) using the plurality of standards to determine a correction factor between a BNP concentration value measured by a reference BNP assay and a BNP concentration value measured by the BNP assay to be corrected, for each of ranges of BNP concentration values measured by a BNP assay to be corrected; and
(B) using the correction factor to correct the BNP concentration value measured in the sample by the BNP assay to be corrected.

### Claim 9 (depends on 7)

The method according to claim 7, further comprising the following steps (1) to (3):
(1) using both a reference BNP assay and a BNP assay to be corrected to measure BNP concentrations in both a first standard and a second standard;
(2) determining, for each of the first standard and the second standard, the following ratio:
[a BNP concentration value measured by the reference BNP assay]/[a BNP concentration value measured by the BNP assay to be corrected]
to determine the ratio for the first standard as a first correction factor and the ratio for the second standard as a second correction factor;
(3) correcting, based on the first correction factor and the second correction factor, an actual measured value which is a BNP concentration value measured in a sample by the BNP assay to be corrected, to the following numerical value:
(i) when the actual measured value is less than or equal to the BNP concentration value of the first standard as measured by the BNP assay to be corrected, a numerical value obtained by multiplying the actual measured value by the first correction factor;
(ii) when the actual measured value is more than the BNP concentration value of the first standard as measured by the BNP assay to be corrected and less than or equal to the BNP concentration value of the second standard as measured by the BNP assay to be corrected, a numerical value obtained by multiplying the actual measured value by a correction factor determined by the following formula:
the first correction factor+[(the second correction factor−the first correction factor)/(the BNP concentration value of the second standard as measured by the BNP assay to be corrected−the BNP concentration value of the first standard as measured by the BNP assay to be corrected)]×(the actual measured value−the BNP concentration value of the first standard as measured by the BNP assay to be corrected); or
(iii) when the actual measured value is more than the BNP concentration value of the second standard as measured by the BNP assay to be corrected, a numerical value obtained by multiplying the actual measured value by the second correction factor.

### Claim 10 (depends on 2)

A BNP assay kit comprising the BNP assay standard set according to claim 2.

### Claim 11 (depends on 3)

A BNP assay kit comprising the BNP assay standard set according to claim 3.

### Claim 12 (depends on 2)

A BNP assay kit comprising information about a correction factor determined using the BNP assay standard set according to claim 2.

### Claim 13 (depends on 3)

A BNP assay kit comprising information about a correction factor determined using the BNP assay standard set according to claim 3.

### Claim 14 (depends on 2)

A method for measuring a BNP concentration in a sample, comprising using the BNP assay standard set according to claim 2.

### Claim 15 (depends on 3)

A method for measuring a BNP concentration in a sample, comprising using the BNP assay standard set according to claim 3.

### Claim 16 (depends on 2)

A method for correcting a BNP concentration value measured in a sample, comprising using the BNP assay standard set according to claim 2.

### Claim 17 (depends on 3)

A method for correcting a BNP concentration value measured in a sample, comprising using the BNP assay standard set according to claim 3.
